EM
Encore MedicalEncore Medical develops transcatheter septal occlusion devices to repair structural heart defects like patent foramen ovale (PFO).
2 Pulse stories
TB
Triveni BioTriveni Bio develops genetics-informed antibody and bispecific therapeutics for immunological and inflammatory diseases.
2 Pulse stories
Total Raised
$272M
Encore MedicalTriveni Bio
Last ValuationNot disclosed
Biotech
Sector
Biotech
2017
Founded
2023
Eagan, Minnesota
HQ
Waltham, Massachusetts
Public (EMI)
Status
Private
Encore Medical investors
No investors on record.
Triveni Bio investors
Atlas VentureCormorant Asset ManagementAscenta CapitalJanus Henderson InvestorsDeep Track CapitalOrbiMedViking Global InvestorsFidelity Management & Research
Data from Value Add Pulse coverage and company research — see the full threads for Encore Medical and Triveni Bio.